BioVie Inc (BIVI) rating initates by Cantor Fitzgerald

BioVie Inc’s recent filing unveils that its Director GORLIN STEVE unloaded Company’s shares for reported $0.13 million on Dec 01 ’23. In the deal valued at $1.69 per share,75,680 shares were sold. As a result of this transaction, GORLIN STEVE now holds 46,358 shares worth roughly $30596.280000000002.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Then, DO CUONG V bought 10,000 shares, generating $17,800 in total proceeds. Upon buying the shares at $1.78, the President & CEO now owns 68,759 shares.

Before that, GORLIN STEVE sold 8,560 shares. BioVie Inc shares valued at $26,108 were divested by the Director at a price of $3.05 per share. As a result of the transaction, GORLIN STEVE now holds 75,680 shares, worth roughly $49948.8.

Cantor Fitzgerald initiated its BioVie Inc [BIVI] rating to an Overweight in a research note published on July 22, 2022; the price target was $7. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in mid January with a ‘”a Buy”‘ rating.

Price Performance Review of BIVI

On Tuesday, BioVie Inc [NASDAQ:BIVI] saw its stock fall -4.64% to $0.66. Over the last five days, the stock has lost -26.61%. BioVie Inc shares have fallen nearly -47.42% since the year began. Nevertheless, the stocks have fallen -91.87% over the past one year. While a 52-week high of $11.39 was reached on 03/01/24, a 52-week low of $0.64 was recorded on 03/11/24. SMA at 50 days reached $1.1304, while 200 days put it at $3.1510. A total of 1.46 million shares were traded, compared to the trading of 2.99 million shares in the previous session.

Levels Of Support And Resistance For BIVI Stock

The 24-hour chart illustrates a support level at 0.6434, which if violated will result in even more drops to 0.6244. On the upside, there is a resistance level at 0.6881. A further resistance level may holdings at 0.7138. The Relative Strength Index (RSI) on the 14-day chart is 36.61, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.3746, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.25%. Stochastics %K at 1.01% indicates the stock is a buying.

How much short interest is there in BioVie Inc?

A steep rise in short interest was recorded in BioVie Inc stocks on Feb 29, 2024, dropping by 70000.0 shares to a total of 1.02 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 1.09 million shares. There was a decline of -6.86%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 6.22% of the overall stock float, the days-to-cover ratio (short ratio) fell to 6.47.

Most Popular